According to this study, over the next five years the Contract Pharmaceutical Manufacturing market will register a 6.1%% CAGR in terms of revenue, the global market size will reach $ 96200 million by 2025, from $ 75850 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Contract Pharmaceutical Manufacturing business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Contract Pharmaceutical Manufacturing market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Contract Pharmaceutical Manufacturing, covering the supply chain analysis, impact assessment to the Contract Pharmaceutical Manufacturing market size growth rate in several scenarios, and the measures to be undertaken by Contract Pharmaceutical Manufacturing companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
- API
- FDF
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
- Specialty/Midsize
- Generics
- Big Pharma
- Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
- Catalent
- AbbVie
- DPx
- Piramal Healthcare
- Aenova
- Lonza
- Boehringer Ingelheim
- Jubilant
- Fareva Holding
- Famar
- NextPharma
- Aesica
- Dishman
- Nipro Corp
- DPT Laboratories
- Sopharma
- Recipharm
- Vetter
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
- To study and analyze the global Contract Pharmaceutical Manufacturing consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
- To understand the structure of Contract Pharmaceutical Manufacturing market by identifying its various subsegments.
- Focuses on the key global Contract Pharmaceutical Manufacturing manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
- To analyze the Contract Pharmaceutical Manufacturing with respect to individual growth trends, future prospects, and their contribution to the total market.
- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
- To project the consumption of Contract Pharmaceutical Manufacturing submarkets, with respect to key regions (along with their respective key countries).
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
- To strategically profile the key players and comprehensively analyze their growth strategies.
Global Contract Pharmaceutical Manufacturing Market Growth 2020-2025
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Contract Pharmaceutical Manufacturing Consumption 2015-2025
2.1.2 Contract Pharmaceutical Manufacturing Consumption CAGR by Region
2.2 Contract Pharmaceutical Manufacturing Segment by Type
2.2.1 API
2.2.2 FDF
2.3 Contract Pharmaceutical Manufacturing Consumption by Type
2.3.1 Global Contract Pharmaceutical Manufacturing Consumption Market Share by Type (2015-2020)
2.3.2 Global Contract Pharmaceutical Manufacturing Revenue and Market Share by Type (2015-2020)
2.3.3 Global Contract Pharmaceutical Manufacturing Sale Price by Type (2015-2020)
2.4 Contract Pharmaceutical Manufacturing Segment by Application
2.4.1 Specialty/Midsize
2.4.2 Generics
2.4.3 Big Pharma
2.4.4 Other
2.5 Contract Pharmaceutical Manufacturing Consumption by Application
2.5.1 Global Contract Pharmaceutical Manufacturing Consumption Market Share by Type (2015-2020)
2.5.2 Global Contract Pharmaceutical Manufacturing Value and Market Share by Type (2015-2020)
2.5.3 Global Contract Pharmaceutical Manufacturing Sale Price by Type (2015-2020)
3 Global Contract Pharmaceutical Manufacturing by Company
3.1 Global Contract Pharmaceutical Manufacturing Sales Market Share by Company
3.1.1 Global Contract Pharmaceutical Manufacturing Sales by Company (2018-2020)
3.1.2 Global Contract Pharmaceutical Manufacturing Sales Market Share by Company (2018-2020)
3.2 Global Contract Pharmaceutical Manufacturing Revenue Market Share by Company
3.2.1 Global Contract Pharmaceutical Manufacturing Revenue by Company (2018-2020)
3.2.2 Global Contract Pharmaceutical Manufacturing Revenue Market Share by Company (2018-2020)
3.3 Global Contract Pharmaceutical Manufacturing Sale Price by Company
3.4 Global Contract Pharmaceutical Manufacturing Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Contract Pharmaceutical Manufacturing Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Contract Pharmaceutical Manufacturing Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Contract Pharmaceutical Manufacturing by Regions
4.1 Contract Pharmaceutical Manufacturing by Regions
4.2 Americas Contract Pharmaceutical Manufacturing Consumption Growth
4.3 APAC Contract Pharmaceutical Manufacturing Consumption Growth
4.4 Europe Contract Pharmaceutical Manufacturing Consumption Growth
4.5 Middle East & Africa Contract Pharmaceutical Manufacturing Consumption Growth
5 Americas
5.1 Americas Contract Pharmaceutical Manufacturing Consumption by Countries
5.1.1 Americas Contract Pharmaceutical Manufacturing Consumption by Countries (2015-2020)
5.1.2 Americas Contract Pharmaceutical Manufacturing Value by Countries (2015-2020)
5.2 Americas Contract Pharmaceutical Manufacturing Consumption by Type
5.3 Americas Contract Pharmaceutical Manufacturing Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Contract Pharmaceutical Manufacturing Consumption by Regions
6.1.1 APAC Contract Pharmaceutical Manufacturing Consumption by Regions (2015-2020)
6.1.2 APAC Contract Pharmaceutical Manufacturing Value by Regions (2015-2020)
6.2 APAC Contract Pharmaceutical Manufacturing Consumption by Type
6.3 APAC Contract Pharmaceutical Manufacturing Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Contract Pharmaceutical Manufacturing by Countries
7.1.1 Europe Contract Pharmaceutical Manufacturing Consumption by Countries (2015-2020)
7.1.2 Europe Contract Pharmaceutical Manufacturing Value by Countries (2015-2020)
7.2 Europe Contract Pharmaceutical Manufacturing Consumption by Type
7.3 Europe Contract Pharmaceutical Manufacturing Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Contract Pharmaceutical Manufacturing by Countries
8.1.1 Middle East & Africa Contract Pharmaceutical Manufacturing Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Contract Pharmaceutical Manufacturing Value by Countries (2015-2020)
8.2 Middle East & Africa Contract Pharmaceutical Manufacturing Consumption by Type
8.3 Middle East & Africa Contract Pharmaceutical Manufacturing Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Contract Pharmaceutical Manufacturing Distributors
10.3 Contract Pharmaceutical Manufacturing Customer
11 Global Contract Pharmaceutical Manufacturing Market Forecast
11.1 Global Contract Pharmaceutical Manufacturing Consumption Forecast (2021-2025)
11.2 Global Contract Pharmaceutical Manufacturing Forecast by Regions
11.2.1 Global Contract Pharmaceutical Manufacturing Forecast by Regions (2021-2025)
11.2.2 Global Contract Pharmaceutical Manufacturing Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Contract Pharmaceutical Manufacturing Forecast by Type
11.8 Global Contract Pharmaceutical Manufacturing Forecast by Application
12 Key Players Analysis
12.1 Catalent
12.1.1 Company Information
12.1.2 Contract Pharmaceutical Manufacturing Product Offered
12.1.3 Catalent Contract Pharmaceutical Manufacturing Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Catalent Latest Developments
12.2 AbbVie
12.2.1 Company Information
12.2.2 Contract Pharmaceutical Manufacturing Product Offered
12.2.3 AbbVie Contract Pharmaceutical Manufacturing Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 AbbVie Latest Developments
12.3 DPx
12.3.1 Company Information
12.3.2 Contract Pharmaceutical Manufacturing Product Offered
12.3.3 DPx Contract Pharmaceutical Manufacturing Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 DPx Latest Developments
12.4 Piramal Healthcare
12.4.1 Company Information
12.4.2 Contract Pharmaceutical Manufacturing Product Offered
12.4.3 Piramal Healthcare Contract Pharmaceutical Manufacturing Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Piramal Healthcare Latest Developments
12.5 Aenova
12.5.1 Company Information
12.5.2 Contract Pharmaceutical Manufacturing Product Offered
12.5.3 Aenova Contract Pharmaceutical Manufacturing Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Aenova Latest Developments
12.6 Lonza
12.6.1 Company Information
12.6.2 Contract Pharmaceutical Manufacturing Product Offered
12.6.3 Lonza Contract Pharmaceutical Manufacturing Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Lonza Latest Developments
12.7 Boehringer Ingelheim
12.7.1 Company Information
12.7.2 Contract Pharmaceutical Manufacturing Product Offered
12.7.3 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Boehringer Ingelheim Latest Developments
12.8 Jubilant
12.8.1 Company Information
12.8.2 Contract Pharmaceutical Manufacturing Product Offered
12.8.3 Jubilant Contract Pharmaceutical Manufacturing Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Jubilant Latest Developments
12.9 Fareva Holding
12.9.1 Company Information
12.9.2 Contract Pharmaceutical Manufacturing Product Offered
12.9.3 Fareva Holding Contract Pharmaceutical Manufacturing Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Fareva Holding Latest Developments
12.10 Famar
12.10.1 Company Information
12.10.2 Contract Pharmaceutical Manufacturing Product Offered
12.10.3 Famar Contract Pharmaceutical Manufacturing Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Famar Latest Developments
12.11 NextPharma
12.11.1 Company Information
12.11.2 Contract Pharmaceutical Manufacturing Product Offered
12.11.3 NextPharma Contract Pharmaceutical Manufacturing Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 NextPharma Latest Developments
12.12 Aesica
12.12.1 Company Information
12.12.2 Contract Pharmaceutical Manufacturing Product Offered
12.12.3 Aesica Contract Pharmaceutical Manufacturing Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Aesica Latest Developments
12.13 Dishman
12.13.1 Company Information
12.13.2 Contract Pharmaceutical Manufacturing Product Offered
12.13.3 Dishman Contract Pharmaceutical Manufacturing Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Dishman Latest Developments
12.14 Nipro Corp
12.14.1 Company Information
12.14.2 Contract Pharmaceutical Manufacturing Product Offered
12.14.3 Nipro Corp Contract Pharmaceutical Manufacturing Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Nipro Corp Latest Developments
12.15 DPT Laboratories
12.15.1 Company Information
12.15.2 Contract Pharmaceutical Manufacturing Product Offered
12.15.3 DPT Laboratories Contract Pharmaceutical Manufacturing Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 DPT Laboratories Latest Developments
12.16 Sopharma
12.16.1 Company Information
12.16.2 Contract Pharmaceutical Manufacturing Product Offered
12.16.3 Sopharma Contract Pharmaceutical Manufacturing Sales, Revenue, Price and Gross Margin (2018-2020)
12.16.4 Main Business Overview
12.16.5 Sopharma Latest Developments
12.17 Recipharm
12.17.1 Company Information
12.17.2 Contract Pharmaceutical Manufacturing Product Offered
12.17.3 Recipharm Contract Pharmaceutical Manufacturing Sales, Revenue, Price and Gross Margin (2018-2020)
12.17.4 Main Business Overview
12.17.5 Recipharm Latest Developments
12.18 Vetter
12.18.1 Company Information
12.18.2 Contract Pharmaceutical Manufacturing Product Offered
12.18.3 Vetter Contract Pharmaceutical Manufacturing Sales, Revenue, Price and Gross Margin (2018-2020)
12.18.4 Main Business Overview
12.18.5 Vetter Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Contract Pharmaceutical Manufacturing Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of API
Table 5. Major Players of FDF
Table 6. Global Consumption Sales by Type (2015-2020)
Table 7. Global Contract Pharmaceutical Manufacturing Consumption Market Share by Type (2015-2020)
Table 8. Global Contract Pharmaceutical Manufacturing Revenue by Type (2015-2020) ($ million)
Table 9. Global Contract Pharmaceutical Manufacturing Value Market Share by Type (2015-2020) ($ Millions)
Table 10. Global Contract Pharmaceutical Manufacturing Sale Price by Type (2015-2020)
Table 11. Global Consumption Sales by Application (2015-2020)
Table 12. Global Contract Pharmaceutical Manufacturing Consumption Market Share by Application (2015-2020)
Table 13. Global Contract Pharmaceutical Manufacturing Value by Application (2015-2020)
Table 14. Global Contract Pharmaceutical Manufacturing Value Market Share by Application (2015-2020)
Table 15. Global Contract Pharmaceutical Manufacturing Sale Price by Application (2015-2020)
Table 16. Global Contract Pharmaceutical Manufacturing Sales by Company (2017-2019) (K Units)
Table 17. Global Contract Pharmaceutical Manufacturing Sales Market Share by Company (2017-2019)
Table 18. Global Contract Pharmaceutical Manufacturing Revenue by Company (2017-2019) ($ Millions)
Table 19. Global Contract Pharmaceutical Manufacturing Revenue Market Share by Company (2017-2019)
Table 20. Global Contract Pharmaceutical Manufacturing Sale Price by Company (2017-2019)
Table 21. Global Contract Pharmaceutical Manufacturing Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players Contract Pharmaceutical Manufacturing Products Offered
Table 23. Contract Pharmaceutical Manufacturing Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global Contract Pharmaceutical Manufacturing Consumption by Regions 2015-2020 (K Units)
Table 25. Global Contract Pharmaceutical Manufacturing Consumption Market Share by Regions 2015-2020
Table 26. Global Contract Pharmaceutical Manufacturing Value by Regions 2015-2020 ($ Millions)
Table 27. Global Contract Pharmaceutical Manufacturing Value Market Share by Regions 2015-2020
Table 28. Americas Contract Pharmaceutical Manufacturing Consumption by Countries (2015-2020) (K Units)
Table 29. Americas Contract Pharmaceutical Manufacturing Consumption Market Share by Countries (2015-2020)
Table 30. Americas Contract Pharmaceutical Manufacturing Value by Countries (2015-2020) ($ Millions)
Table 31. Americas Contract Pharmaceutical Manufacturing Value Market Share by Countries (2015-2020)
Table 32. Americas Contract Pharmaceutical Manufacturing Consumption by Type (2015-2020) (K Units)
Table 33. Americas Contract Pharmaceutical Manufacturing Consumption Market Share by Type (2015-2020)
Table 34. Americas Contract Pharmaceutical Manufacturing Consumption by Application (2015-2020) (K Units)
Table 35. Americas Contract Pharmaceutical Manufacturing Consumption Market Share by Application (2015-2020)
Table 36. APAC Contract Pharmaceutical Manufacturing Consumption by Countries (2015-2020) (K Units)
Table 37. APAC Contract Pharmaceutical Manufacturing Consumption Market Share by Countries (2015-2020)
Table 38. APAC Contract Pharmaceutical Manufacturing Value by Regions (2015-2020) ($ Millions)
Table 39. APAC Contract Pharmaceutical Manufacturing Value Market Share by Regions (2015-2020)
Table 40. APAC Contract Pharmaceutical Manufacturing Consumption by Type (2015-2020) (K Units)
Table 41. APAC Contract Pharmaceutical Manufacturing Consumption Market Share by Type (2015-2020)
Table 42. APAC Contract Pharmaceutical Manufacturing Consumption by Application (2015-2020) (K Units)
Table 43. APAC Contract Pharmaceutical Manufacturing Consumption Market Share by Application (2015-2020)
Table 44. Europe Contract Pharmaceutical Manufacturing Consumption by Countries (2015-2020) (K Units)
Table 45. Europe Contract Pharmaceutical Manufacturing Consumption Market Share by Countries (2015-2020)
Table 46. Europe Contract Pharmaceutical Manufacturing Value by Countries (2015-2020) ($ Millions)
Table 47. Europe Contract Pharmaceutical Manufacturing Value Market Share by Countries (2015-2020)
Table 48. Europe Contract Pharmaceutical Manufacturing Consumption by Type (2015-2020) (K Units)
Table 49. Europe Contract Pharmaceutical Manufacturing Consumption Market Share by Type (2015-2020)
Table 50. Europe Contract Pharmaceutical Manufacturing Consumption by Application (2015-2020) (K Units)
Table 51. Europe Contract Pharmaceutical Manufacturing Consumption Market Share by Application (2015-2020)
Table 52. Middle East & Africa Contract Pharmaceutical Manufacturing Consumption by Countries (2015-2020) (K Units)
Table 53. Middle East & Africa Contract Pharmaceutical Manufacturing Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa Contract Pharmaceutical Manufacturing Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa Contract Pharmaceutical Manufacturing Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Contract Pharmaceutical Manufacturing Consumption by Type (2015-2020) (K Units)
Table 57. Middle East & Africa Contract Pharmaceutical Manufacturing Consumption Market Share by Type (2015-2020)
Table 58. Middle East & Africa Contract Pharmaceutical Manufacturing Consumption by Application (2015-2020) (K Units)
Table 59. Middle East & Africa Contract Pharmaceutical Manufacturing Consumption Market Share by Application (2015-2020)
Table 60. Contract Pharmaceutical Manufacturing Distributors List
Table 61. Contract Pharmaceutical Manufacturing Customer List
Table 62. Global Contract Pharmaceutical Manufacturing Consumption Forecast by Countries (2021-2025) (K Units)
Table 63. Global Contract Pharmaceutical Manufacturing Consumption Market Forecast by Regions
Table 64. Global Contract Pharmaceutical Manufacturing Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global Contract Pharmaceutical Manufacturing Value Market Share Forecast by Regions
Table 66. Global Contract Pharmaceutical Manufacturing Consumption Forecast by Type (2021-2025) (K Units)
Table 67. Global Contract Pharmaceutical Manufacturing Consumption Market Share Forecast by Type (2021-2025)
Table 68. Global Contract Pharmaceutical Manufacturing Value Forecast by Type (2021-2025) ($ Millions)
Table 69. Global Contract Pharmaceutical Manufacturing Value Market Share Forecast by Type (2021-2025)
Table 70. Global Contract Pharmaceutical Manufacturing Consumption Forecast by Application (2021-2025) (K Units)
Table 71. Global Contract Pharmaceutical Manufacturing Consumption Market Share Forecast by Application (2021-2025)
Table 72. Global Contract Pharmaceutical Manufacturing Value Forecast by Application (2021-2025) ($ Millions)
Table 73. Global Contract Pharmaceutical Manufacturing Value Market Share Forecast by Application (2021-2025)
Table 74. Catalent Product Offered
Table 75. Catalent Contract Pharmaceutical Manufacturing Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 76. Catalent Main Business
Table 77. Catalent Latest Developments
Table 78. Catalent Basic Information, Company Total Revenue (in $ million), Contract Pharmaceutical Manufacturing Manufacturing Base, Sales Area and Its Competitors
Table 79. AbbVie Product Offered
Table 80. AbbVie Contract Pharmaceutical Manufacturing Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 81. AbbVie Main Business
Table 82. AbbVie Latest Developments
Table 83. AbbVie Basic Information, Company Total Revenue (in $ million), Contract Pharmaceutical Manufacturing Manufacturing Base, Sales Area and Its Competitors
Table 84. DPx Product Offered
Table 85. DPx Contract Pharmaceutical Manufacturing Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 86. DPx Main Business
Table 87. DPx Latest Developments
Table 88. DPx Basic Information, Company Total Revenue (in $ million), Contract Pharmaceutical Manufacturing Manufacturing Base, Sales Area and Its Competitors
Table 89. Piramal Healthcare Product Offered
Table 90. Piramal Healthcare Contract Pharmaceutical Manufacturing Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 91. Piramal Healthcare Main Business
Table 92. Piramal Healthcare Latest Developments
Table 93. Piramal Healthcare Basic Information, Company Total Revenue (in $ million), Contract Pharmaceutical Manufacturing Manufacturing Base, Sales Area and Its Competitors
Table 94. Aenova Product Offered
Table 95. Aenova Contract Pharmaceutical Manufacturing Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 96. Aenova Main Business
Table 97. Aenova Latest Developments
Table 98. Aenova Basic Information, Company Total Revenue (in $ million), Contract Pharmaceutical Manufacturing Manufacturing Base, Sales Area and Its Competitors
Table 99. Lonza Product Offered
Table 100. Lonza Contract Pharmaceutical Manufacturing Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 101. Lonza Main Business
Table 102. Lonza Latest Developments
Table 103. Lonza Basic Information, Company Total Revenue (in $ million), Contract Pharmaceutical Manufacturing Manufacturing Base, Sales Area and Its Competitors
Table 104. Boehringer Ingelheim Product Offered
Table 105. Boehringer Ingelheim Basic Information, Company Total Revenue (in $ million), Contract Pharmaceutical Manufacturing Manufacturing Base, Sales Area and Its Competitors
Table 106. Boehringer Ingelheim Main Business
Table 107. Boehringer Ingelheim Latest Developments
Table 108. Boehringer Ingelheim Contract Pharmaceutical Manufacturing Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 109. Jubilant Product Offered
Table 110. Jubilant Contract Pharmaceutical Manufacturing Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 111. Jubilant Main Business
Table 112. Jubilant Latest Developments
Table 113. Jubilant Basic Information, Company Total Revenue (in $ million), Contract Pharmaceutical Manufacturing Manufacturing Base, Sales Area and Its Competitors
Table 114. Fareva Holding Product Offered
Table 115. Fareva Holding Contract Pharmaceutical Manufacturing Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 116. Fareva Holding Main Business
Table 117. Fareva Holding Latest Developments
Table 118. Fareva Holding Basic Information, Company Total Revenue (in $ million), Contract Pharmaceutical Manufacturing Manufacturing Base, Sales Area and Its Competitors
Table 119. Famar Product Offered
Table 120. Famar Contract Pharmaceutical Manufacturing Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 121. Famar Main Business
Table 122. Famar Latest Developments
Table 123. Famar Basic Information, Company Total Revenue (in $ million), Contract Pharmaceutical Manufacturing Manufacturing Base, Sales Area and Its Competitors
Table 124. NextPharma Product Offered
Table 125. NextPharma Contract Pharmaceutical Manufacturing Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 126. NextPharma Main Business
Table 127. NextPharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 128. NextPharma Latest Developments
Table 129. Aesica Product Offered
Table 130. Aesica Contract Pharmaceutical Manufacturing Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 131. Aesica Main Business
Table 132. Aesica Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 133. Aesica Latest Developments
Table 134. Dishman Product Offered
Table 135. Dishman Contract Pharmaceutical Manufacturing Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 136. Dishman Main Business
Table 137. Dishman Latest Developments
Table 138. Dishman Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 139. Nipro Corp Product Offered
Table 140. Nipro Corp Contract Pharmaceutical Manufacturing Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 141. Nipro Corp Main Business
Table 142. Nipro Corp Latest Developments
Table 143. Nipro Corp Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 144. DPT Laboratories Product Offered
Table 145. DPT Laboratories Contract Pharmaceutical Manufacturing Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 146. DPT Laboratories Main Business
Table 147. DPT Laboratories Latest Developments
Table 148. DPT Laboratories Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 149. Sopharma Product Offered
Table 150. Sopharma Contract Pharmaceutical Manufacturing Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 151. Sopharma Main Business
Table 152. Sopharma Latest Developments
Table 153. Sopharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 154. Recipharm Product Offered
Table 155. Recipharm Contract Pharmaceutical Manufacturing Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 156. Recipharm Main Business
Table 157. Recipharm Latest Developments
Table 158. Recipharm Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 159. Vetter Product Offered
Table 160. Vetter Contract Pharmaceutical Manufacturing Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 161. Vetter Main Business
Table 162. Vetter Latest Developments
Table 163. Vetter Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Contract Pharmaceutical Manufacturing
Figure 2. Contract Pharmaceutical Manufacturing Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Contract Pharmaceutical Manufacturing Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Contract Pharmaceutical Manufacturing Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of API
Figure 7. Product Picture of FDF
Figure 8. Global Contract Pharmaceutical Manufacturing Consumption Market Share by Type (2015-2020)
Figure 9. Global Contract Pharmaceutical Manufacturing Value Market Share by Type (2015-2020)
Figure 10. Contract Pharmaceutical Manufacturing Consumed in Specialty/Midsize
Figure 11. Global Contract Pharmaceutical Manufacturing Market: Specialty/Midsize (2015-2020) (K Units)
Figure 12. Global Contract Pharmaceutical Manufacturing Market: Specialty/Midsize (2015-2020) ($ Millions)
Figure 13. Contract Pharmaceutical Manufacturing Consumed in Generics
Figure 14. Global Contract Pharmaceutical Manufacturing Market: Generics (2015-2020) (K Units)
Figure 15. Global Contract Pharmaceutical Manufacturing Market: Generics (2015-2020) ($ Millions)
Figure 16. Contract Pharmaceutical Manufacturing Consumed in Big Pharma
Figure 17. Global Contract Pharmaceutical Manufacturing Market: Big Pharma (2015-2020) (K Units)
Figure 18. Global Contract Pharmaceutical Manufacturing Market: Big Pharma (2015-2020) ($ Millions)
Figure 19. Contract Pharmaceutical Manufacturing Consumed in Other
Figure 20. Global Contract Pharmaceutical Manufacturing Market: Other (2015-2020) (K Units)
Figure 21. Global Contract Pharmaceutical Manufacturing Market: Other (2015-2020) ($ Millions)
Figure 22. Global Contract Pharmaceutical Manufacturing Consumption Market Share by Application (2015-2020)
Figure 23. Global Contract Pharmaceutical Manufacturing Value Market Share by Application (2015-2020)
Figure 24. Global Contract Pharmaceutical Manufacturing Sales Market Share by Company in 2017
Figure 25. Global Contract Pharmaceutical Manufacturing Sales Market Share by Company in 2019
Figure 26. Global Contract Pharmaceutical Manufacturing Revenue Market Share by Company in 2017
Figure 27. Global Contract Pharmaceutical Manufacturing Revenue Market Share by Company in 2019
Figure 28. Global Contract Pharmaceutical Manufacturing Sale Price by Company in 2019
Figure 29. Global Contract Pharmaceutical Manufacturing Consumption Market Share by Regions 2015-2020
Figure 30. Global Contract Pharmaceutical Manufacturing Value Market Share by Regions 2015-2020
Figure 31. Americas Contract Pharmaceutical Manufacturing Consumption 2015-2020 (K Units)
Figure 32. Americas Contract Pharmaceutical Manufacturing Value 2015-2020 ($ Millions)
Figure 33. APAC Contract Pharmaceutical Manufacturing Consumption 2015-2020 (K Units)
Figure 34. APAC Contract Pharmaceutical Manufacturing Value 2015-2020 ($ Millions)
Figure 35. Europe Contract Pharmaceutical Manufacturing Consumption 2015-2020 (K Units)
Figure 36. Europe Contract Pharmaceutical Manufacturing Value 2015-2020 ($ Millions)
Figure 37. Middle East & Africa Contract Pharmaceutical Manufacturing Consumption 2015-2020 (K Units)
Figure 38. Middle East & Africa Contract Pharmaceutical Manufacturing Value 2015-2020 ($ Millions)
Figure 39. Americas Contract Pharmaceutical Manufacturing Consumption Market Share by Countries in 2019
Figure 40. Americas Contract Pharmaceutical Manufacturing Value Market Share by Countries in 2019
Figure 41. Americas Contract Pharmaceutical Manufacturing Consumption Market Share by Type in 2019
Figure 42. Americas Contract Pharmaceutical Manufacturing Consumption Market Share by Application in 2019
Figure 43. United States Contract Pharmaceutical Manufacturing Consumption Growth 2015-2020 (K Units)
Figure 44. United States Contract Pharmaceutical Manufacturing Value Growth 2015-2020 ($ Millions)
Figure 45. Canada Contract Pharmaceutical Manufacturing Consumption Growth 2015-2020 (K Units)
Figure 46. Canad
Global Antioxidant Vitamins Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 100
The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
Global Clavulanate Potassium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030.
North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
Global Amoxicillin Sodium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 84
The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030.
North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
Global Melatonin Supplements Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 106
The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 93
The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
Global Sleeping Pills Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 94
The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
Global Zinc Oral Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
Global Zinc Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
Global Anti-Infectives Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 78
The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
